Oral candidiasis is a common fungal infection of the oral cavity caused predominantly by Candida albicans. Conventional antifungal therapies often require frequent administration and may result in inadequate drug concentration at the site of infection. Buccal drug delivery systems offer prolonged residence time, improved patient compliance, and enhanced local therapeutic efficacy. The present study aimed to formulate and evaluate a mucoadhesive buccal patch containing Posaconazole, a broad-spectrum imidazole antifungal agent, for the effective treatment of oral fungal infections.
No takes yet. Share an insight, caveat, or question.
Darji et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: